The survivor panel discussion is one of the most meaningful and anticipated moments of our Annual Symposium on Pancreatic Cancer. Each year, patients and families hear directly from survivors and caregivers willing to share their journeys with honesty, vulnerability, and hope.
In celebration of our 20th Annual Symposium on Pancreatic Cancer, we were grateful to feature a panel of four survivors moderated by Thom Mrozek, a 14-year pancreatic cancer survivor. Thom previously participated as a panelist and returned this year to help guide the conversation when Dr. Annette Stanton was unable to attend.
Diagnosed with Stage 2B pancreatic ductal adenocarcinoma (PDAC), Thom underwent the Whipple surgery followed by FOLFIRINOX chemotherapy. Fourteen years later, Thom continues to live well and inspire others through his advocacy, encouragement, and willingness to share his experience.
This year’s panel featured survivors with different diagnoses, treatment paths, and experiences, each offering valuable insight into navigating pancreatic cancer.
Federico Kalinec, PhD
In December 2012, Federico suddenly developed severe jaundice and gastrointestinal symptoms. A CT scan revealed a large pancreatic tumor compressing the bile duct with extensive metastases, leading to a diagnosis of Stage 4 pancreatic cancer. After emergency surgery to place a bile duct stent, he was initially told he had only months to live.
Fortunately, Dr. Hector Ramos accepted the challenge and performed an extensive Whipple surgery, removing multiple organs and reconstructing part of the portal vein. Federico returned to work within 40 days and initially required only insulin following his pancreatectomy. When additional metastases appeared in later years, he underwent further surgeries and treatments, including Lanreotide and Lutathera.
More than thirteen years later, Federico continues enjoying life and remains a powerful example of perseverance and hope.
“Thus, the two to three months turned into more than 13 years, and I continue enjoying life. As the motto of the Hirshberg Foundation says: Never Give Up!”
Peter Lau
Peter was diagnosed with Stage 4 pancreatic cancer after an abdominal ultrasound revealed a mass during an evaluation for newly diagnosed diabetes. Despite having few symptoms, his diagnosis immediately changed the course of his life.
Over the past two and a half years, Peter has undergone multiple chemotherapy regimens, participated in a clinical trial, and received radiation therapy. Throughout his journey, he has relied on faith, friendship, community, and purpose to move forward.
Peter shared how pancreatic cancer has reshaped his perspective on life, priorities, and relationships.
“The support of organizations like the Hirshberg Foundation, a proactive medical staff, support groups, and a village of personal friends helps me live a life beyond just staying alive.”
Alyce LaViolette
Alyce’s journey began with abdominal discomfort that led her to insist on additional imaging during an emergency room visit. That advocacy led to the discovery of a grapefruit-sized tumor.
What was initially believed to be pre-cancer became a pancreatic cancer diagnosis following a lengthy and complex surgery. Throughout treatment, Alyce continued working and leaned heavily on the support of her partner, family, and friends.
She spoke about the importance of gratitude, connection, and community support throughout treatment.
“I have had a terrific team at Kaiser. I also have a wonderful partner, family, and friends who made this journey one of gratitude.”
Jeanette Reedy Solano, PhD
Jeanette spent nearly ten months seeking answers before receiving her pancreatic cancer diagnosis. Initially told she was inoperable and given limited time to live, she pursued multiple opinions before joining a UCLA clinical trial under Dr. Zev Wainberg and surgical care with Dr. Timothy Donahue.
Through chemotherapy, immunotherapy, nutrition, prayer, acupuncture, yoga Nidra, and unwavering determination, her tumor shrank dramatically prior to surgery.
Today, Jeanette is cancer-free one year after surgery and shares her story to encourage others facing pancreatic cancer.
“Take a deep breath, decide you will live, educate yourself, and clarify what you are living for.”
The survivor panel remains one of the most powerful parts of the Symposium because it reminds us that every pancreatic cancer journey is personal, and that hope, resilience, and community matter.
We are deeply grateful to Thom and all of our panelists for sharing their experiences and helping others feel less alone.
